Document is current
Any future updates will be listed below
-
Authors
Justus, Matthew
Friedrichsen, Debra
Brooks, Bill
Silaski, Grayson
Beckius, Robert
Massie, Pierce
Pace, Carolyn
Kulkarni, Deepali
Self, Trevor
Mattox, Mildred
Bray, Jeffrey
Risotto-Urbanowicz, Erin
Iturralde-Carillo, Andrea
Marek, Jenna
Coffman, Brittany
Heaps, Cristine
Ferguson, Heather
Shekarriz, Reza
Kanagy, Nancy
Clark, Ross
-
Funding
Funding for this research was provided by:
National Institutes of Health (GM144027, AG076027)
National Institutes of Health (GM144027, AG076027, K12TR005467)
- License Information
-
More Information
Article History
Received: 5 November 2025
Accepted: 3 March 2026
First Online: 9 March 2026
Declarations
:
: Animal studies were performed under the OLAW Assurances OLAW Assurance D16-00511 / USDA Registration 74-R-0012 (TAMU) and D16-00228/USDA Registration # 85-R-0014 (UNM).
: Reza Shekarriz is the director of Exhalix LLC, a for-profit R&D organization and commercialization of the device hereto presented in this paper.
